A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells

BACKGROUND: The development of effective cancer vaccines still remains a challenge. Despite the crucial role of plasmacytoid dendritic cells (pDCs) in anti-tumor responses, their therapeutic potential has not yet been worked out. We explored the relevance of HLA-A*0201 matched allogeneic pDCs as vec...

Descripción completa

Detalles Bibliográficos
Autores principales: Aspord, Caroline, Charles, Julie, Leccia, Marie-Therese, Laurin, David, Richard, Marie-Jeanne, Chaperot, Laurence, Plumas, Joel
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864288/
https://www.ncbi.nlm.nih.gov/pubmed/20454561
http://dx.doi.org/10.1371/journal.pone.0010458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864288/
https://www.ncbi.nlm.nih.gov/pubmed/20454561
http://dx.doi.org/10.1371/journal.pone.0010458

Ejemplares similares